Command Palette

Search for a command to run...

Clinical Trials · NCT05218915

Basal Plus GLP1-ra on Glycemic Variability in CKD

CompletedPhase 4Dulaglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Elaine Chow
Enrollment
95
Start date
Jan 2022
Locations
1 site, Hong Kong
Primary endpoint
Glycemic variability
View Dulaglutide compound reference